Reversible human serum albumin binding of lipocrine: A circular dichroism study

Chirality

Volumn 23, Issue 9, 2011, Pages 827-832

  Bertucci, Carlo ^a   De Simone, Angela ^a   Pistolozzi, Marco ^a   Rosini, Michela ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

drug interactions; enantiomers; HSA binding; induced circular dichroism; lipocrine

Indexed keywords

BILIRUBIN; CHOLINESTERASE INHIBITOR; HUMAN SERUM ALBUMIN; LIPOCRINE; UNCLASSIFIED DRUG;

ARTICLE; BILIRUBIN BINDING; BINDING SITE; CIRCULAR DICHROISM; DRUG BINDING; ENANTIOMER; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SPECTROSCOPY; STEREOCHEMISTRY;

BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; HUMANS; MOLECULAR STRUCTURE; PROTEIN BINDING; SERUM ALBUMIN; TACRINE; THIOCTIC ACID;

EID: 80052805320     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.21006     Document Type: Article

References (30)

1. Kragh-Hansen U,. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990; 37: 57-84.
2. Noctor TA, Wainer IW, Hage DS,. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. J Chromatogr 1992; 577: 305-315.
3. Peters T Jr,. All about albumin, biochemistry, genetics, and medical applications. New York: Academic Press; 1996.
4. Bertucci C, Domenici E,. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 2002; 9: 1463-1481. (Pubitemid 34823027)
5. Ascoli GA, Domenici E, Bertucci C,. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 2006; 18: 667-679. (Pubitemid 44408409)
6. Nicholson JP, Wolmarans MR, Park GR,. The role of albumin in critical illness. Br J Anaesth 2000; 85: 599-610.
7. Pistolozzi M, Bertucci C,. Species-dependent stereoselective drug binding to albumin: a circular dichroism study. Chirality 2008; 20: 552-558. (Pubitemid 351303995)
8. Harder S, Thurmann P,. Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 1996; 30: 416-444.
9. Ghuman J, Zunszain PA, Petipas I, Bhattacharya AA, Otagiri M, Curry S,. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 2005; 353: 38-52. (Pubitemid 41338838)
10. Karnaukhova E,. Interactions of human serum albumin with retinoic acid, retinal and retinyl acetate. Biochem Pharmacol 2007; 73: 901-910. (Pubitemid 46227336)
11. Bertucci C, Pistolozzi M, Felix G, Danielson UH,. HSA binding of HIV protease inhibitors: a high-performance affinity chromatography study. J Sep Sci 2009; 32: 1625-1631.
12. Daneshgar P, Moosavi-Movahedi AA, Norouzi P, Ganjali MR, Madadkar-Sobhani A, Saboury AA,. Molecular interaction of human serum albumin with paracetamol: spectroscopic and molecular modeling studies. Int J Biol Macromol 2009; 45: 129-134.
13. Zsila F, Fitos I,. Combination of chiroptical, absorption and fluorescence spectroscopic methods reveals multiple, hydrophobicity-driven human serum albumin binding of the antimalarial atovaquone and related hydroxynaphthoquinone compounds. Org Biomol Chem 2010; 8: 4905-4914.
14. 1-acid glycoprotein for chromatographic studies of drug-protein binding. Anal Biochem 2005; 346: 300-310. (Pubitemid 41550261)
15. Zsila F, Iwao Y,. The drug binding site of human α1-acid glycoprotein: insight from induced circular dichroism and electronic absorption spectra. Biochim Biophys Acta 2007; 1770: 797-809. (Pubitemid 46412640)
16. Fitos I, Visy J, Simonyi M, Mády G, Zsila F,. Selective binding interactions of deramciclane to the genetic variants of human alpha(1)-acid glycoprotein. Biochim Biophys Acta 2010; 1800: 367-372.
17. Rosini M, Andrisano V, Bartolini M, Bolognesi ML, Hrelia P, Minarini A, Tarozzi A, Melchiorre C,. Rational approach to discover multipotent anti-Alzheimer drugs. J Med Chem 2005; 48: 360-363. (Pubitemid 40139781)
18. Bolognesi ML, Cavalli A, Bergamini C, Fato R, Lenaz G, Rosini M, Bartolini M, Andrisano V, Melchiorre C,. Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks. J Med Chem 2009; 52: 7883-7886.
19. Bolognesi ML, Rosini M, Andrisano V, Bartolini M, Minarini A, Tumiatti V, Melchiorre C,. MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond. Curr Pharm Des 2009; 15: 601-613.
20. Bongarzone S, Tran NHA, Cavalli A, Roberti M, Rosini M, Carloni P, Legname G, Bolognesi ML,. Hybrid lipoic acid derivatives to attack prion disease on multiple fronts. Chem Med Chem 2011; 6: 601-605.
21. Bertucci C, Pistolozzi M, Felix G, Danielson UH,. HSA binding of HIV protease inhibitors: a high performance affinity chromatography study. J Sep Sci 2009; 32: 1625-1631.
22. Wainer IW, Kaliszan R, Noctor TA,. Biochromatography using immobilized biopolymers: a new approach to the determination of pharmacological properties. J Pharm Pharmacol 1993; 45: 367-373. (Pubitemid 23123552)
23. Kragh-Hansen U,. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Mol Pharmacol 1988; 34: 160-171.
24. Jenkins BG, Lauffer RB,. Detection of site-specific binding and co-binding of ligands to human serum albumin using 19F NMR. Mol Pharmacol 1990; 37: 111-118. (Pubitemid 20038458)
25. Bjerrum OJ,. Interaction of bromophenol blue and bilirubin with bovine and human serum albumin determined by gel filtration. Scand J Clin Lab Invest 1968; 22: 41-48.
26. Kragh-Hansen U, Chuang VTG, Otagiri M,. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002; 25: 695-704. (Pubitemid 40036701)
27. Sudlow G, Birkett DJ, Wade DN,. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975; 11: 824-832.
28. Lightner DA, Wijekoon WM, Zhang MH,. Understanding bilirubin conformation and binding. Circular dichroism of human serum albumin complexes with bilirubin and its esters. J Biol Chem 1988; 263: 16669-16676.
29. Petersen CE, Ha C-E, Harohalli K, Feix JB, Bhagavan NV,. A dynamic model for bilirubin binding to human serum albumin. J Biol Chem 2000; 275: 20985-20995. (Pubitemid 30481786)
30. Boiadjiev SE, Lightner DA,. Exciton chirality of bilirubin homologs. Chirality 1997; 9: 604-615. (Pubitemid 27430455)